211 related articles for article (PubMed ID: 16723595)
21. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
22. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
Fernández-Silva F; Capilla J; Mayayo E; Guarro J
Mycoses; 2014 Feb; 57(2):121-4. PubMed ID: 23879298
[TBL] [Abstract][Full Text] [Related]
23. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
24. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Ruíz-Cendoya M; Pastor J; Guarro J
Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
[TBL] [Abstract][Full Text] [Related]
25. Alternatives to amphotericin B for Candida rugosa infection.
Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
28. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant.
Dua V; Yadav SP; Oberoi J; Sachdeva A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):237-8. PubMed ID: 23211690
[No Abstract] [Full Text] [Related]
31. Comment: caspofungin acetate for treatment of invasive fungal infections.
Chan J
Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
[No Abstract] [Full Text] [Related]
32. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
[TBL] [Abstract][Full Text] [Related]
33. Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Falk R; Wolf DG; Shapiro M; Polacheck I
J Clin Microbiol; 2003 Feb; 41(2):911. PubMed ID: 12574315
[No Abstract] [Full Text] [Related]
34. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
[TBL] [Abstract][Full Text] [Related]
35. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ
Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561
[No Abstract] [Full Text] [Related]
36. Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Kudo K; Terui K; Sasaki S; Kamio T; Sato T; Ito E
Bone Marrow Transplant; 2011 Feb; 46(2):310-1. PubMed ID: 20436525
[No Abstract] [Full Text] [Related]
37. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
38. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
Calvo E; Pastor FJ; Rodríguez MM; Pujol I; Guarro J
Antimicrob Agents Chemother; 2010 Oct; 54(10):4074-7. PubMed ID: 20625150
[TBL] [Abstract][Full Text] [Related]
39. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G
Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976
[TBL] [Abstract][Full Text] [Related]
40. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
